Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, dal 1982 In collaborazione con l'Associazione Culturale Pediatri

Caso contributivo

PDF MeBrain

Kawasaki? Adenovirus? Kawasaki da adenovirus o con adenovirus?

Kawasaki disease? Adenovirus infection? Kawasaki disease triggered by adenovirus or Kawasaki disease with adenovirus?

Francesco Accomando1,2, Melodie O. Aricò1, Enrico Valletta1
1UO di Pediatria, Ospedale “G.B. Morgagni - L. Pierantoni”, Forlì, AUSL della Romagna
2Scuola di Specializzazione in Pediatria, Università di Bologna

Gennaio 2023 | DOI: 10.53126/MEBXXVIGE006

Abstract
Kawasaki disease (KD) still represents a challenge for differential diagnosis because it shares clinical features with other infectious diseases. Adenovirus infection has many symptoms that can be found among the diagnostic criteria of KD. However, the two entities have some minor differences that are useful to distinguish them. It is quite important, even with a positive PCR test for adenovirus, not to exclude a possible KD to avoid a diagnosis delay and possible severe complications.
Riassunto
La malattia di Kawasaki (MK) rappresenta ancora oggi una sfida di diagnosi differenziale con patologie dalla presentazione clinica sovrapponibile. L’infezione da adenovirus è una di queste, poiché condivide molti sintomi che sono anche criteri diagnostici di MK. Le due entità presentano tuttavia alcune minime differenze utili per distinguerle. È importante non distoglierci troppo dal sospetto di MK, anche di fronte a una documentata presenza di adenovirus nelle secrezioni respiratorie, per non ritardare una diagnosi importante.
Contenuto riservato

Per leggere l'articolo è necessario effettuare il login.

Per l'acquisto del singolo articolo scrivi a abbonamenti@medicoebambino.com (la mail si prepara da sola con gli estremi dell'articolo); se accedi, la richiesta parte con un click.

Bibliografia

  1. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart Association [published correction appears in Circulation 2019;140(5):e181-4]. Circulation 2017;135(17):e927-99. doi: 10.1161/CIR.0000000000000484.
  2. Marchesi A, Tarissi de Jacobis I, Rigante D, et al. Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase. Ital J Pediatr 2018;44(1):102. doi: 10.1186/s13052-018-0536-3.
  3. Marchesi A, Rigante D, Cimaz R, et al. Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease. Ital J Pediatr 2021;47(1):16. doi: 10.1186/s13052-021-00962-4.
  4. Newburger JW, Takahashi M, Burns JC. Kawasaki disease. J Am Coll Cardiol 2016;67(14):1738-49. doi: 10.1016/j.jacc.2015.12.073.
  5. Barone SR, Pontrelli LR, Krilov LR. The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection: use of clinical features and a rapid direct fluorescent antigen test. Arch Pediatr Adolesc Med 2000;154(5):453-6. doi: 10.1001/archpedi.154.5.453.
  6. Kim JH, Kang HR, Kim SY, Ban JE. Discrimination of Kawasaki disease with concomitant adenoviral detection differentiating from isolated adenoviral infection. Korean J Pediatr 2018;61(2):43-48. doi: 10.3345/kjp.2018.61.2.43.
  7. Song E, Kajon AE, Wang H, et al. Clinical and virologic characteristics may aid distinction of acute adenovirus disease from Kawasaki disease with incidental adenovirus detection. J Pediatr 2016;170:325-30. doi: 10.1016/j.jpeds.2015.11.021.
  8. Gámez-González LB, Peña-Varela C, Ramírez-López JM, Yamazaki-Nakashimada MA. Adenoviral-induced rash and mucositis: expanding the spectrum of reactive infectious mucocutaneous eruption. Pediatr Dermatol 2021;38(1):306-8. doi: 10.1111/pde.14419.
  9. Watanabe T. Pyuria in patients with Kawasaki disease. World J Clin Pediatr 2015;4(2):25-9. doi: 10.5409/wjcp.v4.i2.25.
  10. Panizon F. L’infezione da adenovirus. Medico e Bambino 2004;23(1):47-9.
  11. Biserni GB, Scarpini S, Dondi A, et al. Potential diagnostic and prognostic biomarkers for adenovirus respiratory infection in children and young adults. Viruses 2021;13(9):1885. doi: 10.3390/v13091885.
  12. Choi JE, Kang HW, Hong YM, Sohn S. C-reactive protein and N-terminal pro-brain natriuretic peptide discrepancy: a differentiation of adenoviral pharyngoconjunctival fever from Kawasaki disease. Korean J Pediatr 2018;61(1):12-6. doi: 10.3345/kjp.2018.61.1.12.
  13. Jaggi P, Kajon AE, Mejias A, Ramilo O, Leber A. Human adenovirus infection in Kawasaki disease: a confounding bystander? Clin Infect Dis 2013;56(1):58-64. doi: 10.1093/cid/cis807.
  14. Song E, Wang H, Kajon AE, et al. Diagnosis of pediatric acute adenovirus infections: is a positive PCR sufficient? Pediatr Infect Dis J 2016;35(8):827-34. doi: 10.1097/INF.0000000000001119.
  15. Schjelderup Nilsen HJ, Nordbø SA, Krokstad S, Døllner H, Christensen A. Human adenovirus in nasopharyngeal and blood samples from children with and without respiratory tract infections. J Clin Virol 2019;111:19-23. doi: 10.1016/j.jcv.2018.12.005.
  16. Leruez-Ville M, Minard V, Lacaille F, et al. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis 2004;38(1):45-52. doi: 10.1086/380450.
  17. Giray T, Biçer S, Küçük Ö, et al. Four cases with Kawasaki disease and viral infection: aetiology or association. Infez Med 2016;24(4):340-4.
  18. Chang LY, Lu CY, Shao PL, et al. Viral infections associated with Kawasaki disease. J Formos Med Assoc 2014;113(3):148-54. doi: 10.1016/j.jfma.2013.12.008.